Stricter Vaccine Approval Rules Coming From FDA
WEDNESDAY, Sept. 23, 2020 -- Stricter guidelines for emergency authorization use of a vaccine against the new coronavirus could soon be issued by the U.S. Food and Drug Administration.
The guidelines would outline more specific criteria for clinical trial data and recommend the data be reviewed by a committee of independent experts before the FDA authorizes any vaccine, people familiar with the draft told The New York Times.
If approved by the White House, the revised guidelines could be released as early as next week.
The move to tighten the rules on emergency vaccine approval come as President Donald Trump keeps promising that a vaccine will be available as early as next month, The Times reported.
© 2020 HealthDay. All rights reserved.
Posted: September 2020
Further Support and Information on COVID-19
Read this next
FRIDAY, Oct. 23, 2020 -- Vaccination coverage with many recommended vaccines is high by age 24 months, according to research published in the Oct. 23 issue of the U.S. Centers for...
THURSDAY, Oct. 22, 2020 -- The first company to start a phase 3 trial of a COVID-19 vaccine reached its target of enrolling 30,000 participants, CNN reported Thursday. The...
WEDNESDAY, Oct. 21, 2020 -- Anthony Fauci, M.D., the leading infectious disease expert in the United States, said on Wednesday he is "cautiously optimistic" that a COVID-19...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.